Back
Blueprint Medicines Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56
BPMC
Blueprint Medicines
Last Price:
$129.49
Seasonality Move:
2.16%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing selling pressure, which indicates risk of future bearish movement.
Blueprint Medicines Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 129 | Buy |
20-day SMA: | 128.54 | Buy |
50-day SMA: | 117.62 | Buy |
200-day SMA: | 99.24 | Buy |
8-day EMA: | 129.04 | Buy |
20-day EMA: | 127.35 | Buy |
50-day EMA: | 118.89 | Buy |
200-day EMA: | 102.94 | Buy |
Blueprint Medicines Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.96 | Buy |
Relative Strength Index (14 RSI): | 76.08 | Buy |
Chaikin Money Flow: | -16549689 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (127.98 - 128.9) | Buy |
Bollinger Bands (100): | (85.19 - 120.91) | Buy |
Blueprint Medicines Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Blueprint Medicines Stock
Is Blueprint Medicines Stock a Buy?
-
Blueprint Medicines share price is 129.28 while BPMC 8-day simple moving average is 129.00, which is a Buy signal.
-
The stock price of BPMC is 129.28 while Blueprint Medicines 20-day SMA is 128.54, which makes it a Buy.
-
Blueprint Medicines 50-day simple moving average is 117.62 while BPMC share price is 129.28, making it a Buy technically.
-
BPMC stock price is 129.28 and Blueprint Medicines 200-day simple moving average is 99.24, creating a Buy signal.
BPMC Technical Analysis vs Fundamental Analysis
Buy
56
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines a Buy or a Sell?
-
Blueprint Medicines stock is rated a BuyThe current Blueprint Medicines [BPMC] share price is $129.28. The Score for BPMC is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Blueprint Medicines Stock Info
Market Cap:
8.3B
Price in USD:
129.28
Share Volume:
25.7M
Blueprint Medicines 52-Week Range
52-Week High:
129.65
52-Week Low:
73.04
Buy
56
Blueprint Medicines (BPMC)
is a Buy
Blueprint Medicines Share Price Forecast
-
What is the Blueprint Medicines stock price today?The Blueprint Medicines stock price is 129.28 USD today.
-
Will BPMC stock go up or go down?Blueprint Medicines> share price is forecast to RISE/FALL based on technical indicators
-
Is Blueprint Medicines overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Blueprint Medicines is not overvalued.
Is Blueprint Medicines Stock a Buy?
-
Blueprint Medicines share price is 129.28 while BPMC 8-day exponential moving average is 129.04, which is a Buy signal.
-
The stock price of BPMC is 129.28 while Blueprint Medicines 20-day EMA is 127.35, which makes it a Buy.
-
Blueprint Medicines 50-day exponential moving average is 118.89 while BPMC share price is 129.28, making it a Buy technically.
-
BPMC stock price is 129.28 and Blueprint Medicines 200-day simple moving average is 102.94, creating a Buy signal.
Fundamental Analysis of Blueprint Medicines
Is Blueprint Medicines a good investment?
-
Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.
Technical Analysis of Blueprint Medicines
Should I short Blueprint Medicines stock?
-
BPMC Moving Average Covergence Divergence (MACD) indicator is 2.96, suggesting Blueprint Medicines is a Buy
-
Blueprint Medicines Relative Strength Index (RSI) is 76.08, which suggest Blueprint Medicines is overbought
-
The Bollinger Bands (25) for Blueprint Medicines is (127.98 - 128.9), which suggest Blueprint Medicines is a Buy
-
The Bollinger Bands (100) for Blueprint Medicines is (85.19 - 120.91), which suggest Blueprint Medicines is a Buy
* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.